Get the Stockscreener App
1.25
15.17%
-0.20
Aethlon Medical Inc stock is traded at $1.25, with a volume of 419.64K.
It is down -15.17% in the last 24 hours and down -38.19% over the past month.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
See More
Previous Close:
$1.45
Open:
$1.28
24h Volume:
419.64K
Relative Volume:
3.24
Market Cap:
$4.06M
Revenue:
$294.20K
Net Income/Loss:
$-12.25M
P/E Ratio:
-0.2475
EPS:
-5.05
Net Cash Flow:
$-10.77M
1W Performance:
-0.81%
1M Performance:
-38.19%
6M Performance:
+84.44%
1Y Performance:
+204.15%
1-Day Range:
$1.23
$1.28
1-Week Range:
$1.13
$1.58
52-Week Range:
$0.2375
$2.875
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
1.235 | 4.06M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
134.12 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.27 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
392.29 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.47 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.26 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Aethlon Medical Inc Stock (AEMD) Latest News
AEMD Reaches Milestone in Australian Hemopurifier Trial | AEMD Stock News - GuruFocus
Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial | AEMD Stock News - GuruFocus
Cancer Trial Breakthrough: Aethlon's Hemopurifier Shows Promise in Treating Therapy-Resistant Tumors - Stock Titan
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier By Investing.com - Investing.com South Africa
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier - Investing.com Nigeria
Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream - GlobeNewswire Inc.
AEMD: Virtual Meeting With Management, Upcoming Presentation of Data in Long Covid - Yahoo Finance
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Drop in Short Interest - Defense World
Medical Tech NewsAethlon Medical (NASDAQ: AEMD) to Present New Pre-Clinical Data on Long COVID and Post-Acute Infection Syndromes - Investorideas.com
AEMD to Present on Long COVID at Keystone Symposium | AEMD Stock News - GuruFocus
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes | AEMD Stock News - GuruFocus
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes - Yahoo Finance
Potential Long COVID Treatment Breakthrough: Aethlon Medical's Device Shows Promise for 48M Patients - Stock Titan
AEMD Trading Halted Pending Important Announcement | AEMD Stock News - GuruFocus
Exosome Therapy Market May See a Big Move | Major Giants- Exiqon, Exosome Diagnostic, NanoSomix - openPR.com
aethlon medical announces reverse stock split effective june 6 By Investing.com - Investing.com South Africa
Aethlon Medical Approves Reverse Stock Split Plan - TipRanks
aethlon medical announces reverse stock split effective june 6 - Investing.com
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update - Defense World
Exosomes Market Projected to Reach USD 1,311.03 Million by - GlobeNewswire
Aethlon Adds to Board - Medical Product Outsourcing
FDA Grants Aethlon Compassionate Use Approval for its Hemopurifier to Help Fight Ebola - Medical Product Outsourcing
FDA OKs Aethlon to Export Hemopurifier to India - Medical Product Outsourcing
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtrati - GuruFocus
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtration System | AEMD Stock News - GuruFocus
Aethlon Medical Announces Publication of Preclinical Data Showin - GuruFocus
Revolutionary Blood Filtration Device Shows 98.5% Success Rate in Cancer and Alzheimer's Treatment Study - Stock Titan
Aethlon Medical Approves Key Stockholder Proposals - TipRanks
Comparing Paragon 28 (NYSE:FNA) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Decline in Short Interest - Defense World
AEMDAethlon Medical Latest Stock News & Market Updates - Stock Titan
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Exosomes Market Size, Top Share, and Industry Analysis Report by 2033 - Straits Research
Virtu Financial LLC Buys Shares of 94,173 Aethlon Medical, Inc. (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 46.7% in March - Defense World
Aethlon Medical at Emerging Growth Virtual Conference: Oncology Focus and Financial Strategy - Investing.com
Aethlon Medical (NASDAQ:AEMD) & Nephros (NASDAQ:NEPH) Head to Head Comparison - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com - Defense World
Aethlon Medical issues new warrants, modifies rights By Investing.com - Investing.com Australia
Aethlon Medical issues new warrants, modifies rights - Investing.com
Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Drops By 52.0% - Defense World
HC Wainwright Reiterates Buy Rating for Aethlon Medical (NASDAQ:AEMD) - The AM Reporter
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):